Bioray Biotech Co., Ltd (TPEX:7561)

Market Cap	563.60M -9.9%
Revenue (ttm)	222.73M +10.4%
Net Income	32.25M +3,118.6%
EPS	1.09 +3,533.3%
Shares Out	29.59M
PE Ratio	17.48
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,204
Open	18.10
Previous Close	18.80
Day's Range	18.10 - 19.05
52-Week Range	16.90 - 32.10
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Bioray Biotech

Bioray Biotech Co., Ltd engages in the production, research, and sells health foods, immune cell products, and precision testing services in Taiwan. It offers health care products, including various functional foods and supplements; medicinal fungi; immune cell products; and precision medicine services, such as immunology, cell division, and specialized laboratory testing. The company is also involved in the cell testing and storage business. Bioray Biotech Co., Ltd was founded in 2005 and is based in Tainan City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7561

Financial Performance

In 2025, Bioray Biotech's revenue was 222.73 million, an increase of 10.42% compared to the previous year's 201.71 million. Earnings were 32.25 million, an increase of 3118.56%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error